PRCT - Procept Biorobotics Corp logo

Procept Biorobotics Corp

PRCT
Revenue grew 100% of years5Y
Compare PRCT Hold

Procept BioRobotics develops and sells the AquaBeam and HYDROS robotic systems, which provide image-guided, minimally invasive surgical solutions for urology, focusing on treating benign prostatic hyperplasia and related urinary tract symptoms.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$467today

Score Overview

1 Year
Score
Net Growth-14.84%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth9.51%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.2
Net Growth-83.37%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth9x
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Score
Net Growth-83.37%
Net Trend20%
Net Income Consistency
Rev Growth9x
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Procept Biorobotics Corp has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PRCT does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 19.96โ€”
1 Year2025-10-23
$ 34.62-42.35%
5 Years2021-10-22
$ 42.74-53.30%
All Time2021-09-15
$ 41.94-52.41%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 337M-$ 109M$ 227M
2025$ 308M-$ 95M$ 286M
2024$ 224M-$ 91M$ 333M
2023$ 136M-$ 105M$ 257M
2022$ 75M-$ 87M$ 222M
IPO2021$ 34M-$ 59M$ 304M
PRCT - Procept Biorobotics Corp logo

Procept Biorobotics Corp fundamental performance

Between 2021 and 2025, revenue grew from $ 34M to $ 308M and net income went from -$ 59M to -$ 95M. Revenue increased in 100% of the years measured; net income in 20%.

Procept Biorobotics Corp currently holds a 5-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.

Membership

Explore PRCT with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies